期刊文献+

半乳凝素-3在宫颈上皮内瘤变及宫颈鳞状细胞癌中的表达及其意义 被引量:3

Expression and Clinical Significance of Galectin-3 in Cervical Intraepithelial Neoplasia and Cervical Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:探讨半乳凝素-3(Galectin-3)在宫颈上皮内瘤变(CIN)及宫颈鳞状细胞癌(SCC)中的表达及其意义。方法:选择经病理确诊为CIN和SCC患者的石蜡标本60例,以同时期因子宫肌瘤行全子宫切除患者的正常宫颈组织(NC)石蜡标本10例作为对照,采用免疫组化方法分析CIN及SCC中Galectin-3表达情况。结果:NC、CIN、SCC及SCCⅠ、SCCⅡ、SCCⅢ组Galectin-3表达阳性率分别为40.00%、50.00%、83.33%及70.00%、90.00%、90.00%。NC、CIN、SCC3组间Galectin-3表达阳性率差异有统计学意义(χ2=9.559,P=0.049);NC组Galectin-3表达阳性率与SCCⅡ期组及Ⅲ期组比较,差异有统计学意义(χ2=5.495,P=0.029)。宫颈肿瘤>2cm组Galectin-3表达阳性率高于≤2cm组,差异有统计学意义(χ2=4.690,P=0.047)。结论:SCC中Galectin-3的阳性表达与肿瘤大小有关;Galectin-3表达阳性率随宫颈病变发展而升高。Galectin-3可能在SCC的发生、进展中发挥作用。 Objective:To investigate the expression and role of Galectin-3 in cervical intraepithelial neoplasia(CIN) and squamous cell carcinoma(SCC).Methods:60 paraffin samples with CIN and SCC diagnosed by pathology were selected,and 10 cases of normal cervical(NC) tissue taken from hysterectomy uterus because of leiomyoma were as control.The expression of Galectin-3 in CIN and SCC were detected by immunohistochemistry.Results:In NC,CIN,SCC and SCC stage Ⅰ-Ⅲ,the positive expression rate of Galectin-3 were 40.00%、50.00%、83.33%、70.00%、90.00% and 90.00% respectively.There was significant difference of positive expression rate of Galectin-3 in NC、CIN and SCC group(χ2=9.559,P =0.049).The positive expression rate of Galectin-3 in SCC stage Ⅱ and Ⅲ were significantly greater than that in NC group(χ2=5.495,P=0.029).There was statistical difference of Galectin-3 expression between tumor sizes more than 2 cm and less than 2 cm(χ2=4.690,P=0.047).Conclusions:The positive Galectin-3 expression in SCC is associated with tumor sizes,but is no relationship with tumor differentiation.The positive expression rate of Galectin-3 is high with progression of cervical lesions.Galectin-3 may play some important roles in the occurrence and progression of SCC.
作者 杨承纲
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2012年第2期105-107,共3页 Journal of Practical Obstetrics and Gynecology
关键词 半乳凝素-3 宫颈上皮内瘤变 宫颈鳞状细胞癌 免疫组化 Galectin-3 Cervical intraepithelial neoplasia Cervical squamous cell carcinoma Immunohistochemistry
  • 相关文献

参考文献11

  • 1Umemoto K,Leffer H,Venot A,et al.Conformational differences in liganded and unliganded states of Galcetin-3[J].Biochemistry,2003,42(10):3688-3695.
  • 2Oiga VG,James RT,Kenneth JP,et al.Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumor cells[J].J Physiol,2003,544(1):89-99.
  • 3Muller S,Schaffer T,Flogerzi B,et al.Galectin-3modulatesT cell activity and is reduced in the inflamed intestinal epithelium in IBD[J].Inflamm Bowel Dis,2006,12(7):588-597.
  • 4许斌,佟敏,姜彦多.Galectin-3和Smad4在大肠癌中的表达和意义[J].临床医药实践,2010,19(6X):672-674. 被引量:1
  • 5Kidong Kim,Rongyu Zang,Seok-Cheol Choi,et al.Current status of gynecological cancer in China[J].J Gynecol Oncol Vol,2009,20(2):72-76.
  • 6Hermann B,Dominik R,Susanna N.Galectin-3expression in normal,hyperlastic,and neoplastic endometrial tissues[J].Pathol Res,2003,199(3):151-158.
  • 7Pratima Nangia-Makker,Vitaly Balan,Avraham Raz.Regulation of tumor progression by extracellular galectin-3[J].Cancer Microenvironment,2008,1(1):43-51.
  • 8Yi Wang,Pratima Nangia-Makker,Larry Tait,et al.Regulation of prostate cancer progression by Galcetin-3[J].Am J Pathol,2009,174(4):15151523.
  • 9曹鸿艳,蔡莉.Galectin-3在乳腺癌中的研究进展[J].实用肿瘤学杂志,2008,22(1):76-78. 被引量:6
  • 10郭一川,阿地力江.伊明,拉莱.苏祖克.SKP2、p27、Galectin-3在子宫颈上皮内瘤变中的表达及其意义[J].新疆医科大学学报,2008,31(4):412-414. 被引量:6

二级参考文献32

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2马婵娟,金晖,孙子林.Galectin-3与糖尿病慢性并发症[J].国外医学(内分泌学分册),2005,25(B04):21-24. 被引量:2
  • 3杨志明,伍晓汀,何涛.Galectin-3与肿瘤转移[J].中国普外基础与临床杂志,2005,12(3):310-313. 被引量:21
  • 4拉莱·苏祖克.新疆不同民族妇女2727例子宫颈癌病理统计分析[J].新疆医学院学报,1990,7(2):49-49.
  • 5Inohara H, Akahani S, Raz A. Galectin-3 stimulates cell proliferation [J]. Exp Cell Res,1998;245(2) : 294-302
  • 6Riss D,Jin L,Qian X, et al. Differential expression of galectin-3 in pituitary tumors [J]. Cancer Res, 2003 ;63(9) :2251-2255
  • 7Nangia-Makker P, Honjo Y, Sarvis R,et al. Galectin-3 induces endothelial c-ell morphogenesis and angiogenesis [ J ]. Am J Pathol, 2000,156 : 899-909
  • 8Moon BK,Lee YJ,Battle P,et al. Galectin-3 protects human breast carcinoma ceils against nitric oxide-induced apoptosis:implication of galectin-3 function during metastasis [ J ]. Am J Pathol, 2001 ; 159 (3) : 1055-1060
  • 9Riss D, Jin L, Qian X et al. Differential expression of galectin-3 in pituitary Tumors [ J ]. Cancer Research, 2003 ;63 ( 9 ) : 2251
  • 10Glinsky VV, Glinsky GV, Rittenhouse-Olson K, et al. The tole of Thomsen-Fr-iedenreich antigen in adhedsion of human breast and prostate cancer ceils to the endothelium [ J ]. Cancer Res,2001;61 (12) :4851

共引文献9

同被引文献39

  • 1曹占伟,于维雅.老年冠心病患者心血管事件的危险因素与药物治疗效果[J].中国老年学杂志,2014,34(4):882-884. 被引量:20
  • 2孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白[J].生物化学与生物物理进展,2007,34(8):856-864. 被引量:21
  • 3刘嵘,濮德敏,程铭,尹伶,李天.Galectin-3蛋白在宫颈病变组织中的表达及意义[J].中国妇幼保健,2007,22(28):4007-4010. 被引量:5
  • 4Yu F, Finley R J, Raz A, et al. Galectin3 translocates to the perinuclear membranes and inhibitscytochrome c release from the mitochondria. A role for synexin in galectin3 translocation[J]. J.
  • 5Ji H, Moritz R L, Kim Y S, et al. Analysis of Rasinduced oncogenic transformation of NIH3T3 cells using differentialdisplay 2DE proteomics[J]. Electrophoresis, 2007,28(12):1997-2008.
  • 6Naidu D G, Raha A, Chen X L, et al. Partial truncation of the NH2terminus affects physical characteristics and membrane binding, aggregation, and fusion properties of annexin A7[J]. Biochim Biop.
  • 7Srivastava M, Bubendorf L, Raffeld M, et al. Prognostic impact of ANX7GTPase in metastatic and HER2 negative breast cancer patients[J]. Clin Cancer Res, 2004,10(7):2344-50.
  • 8Shekhar M P, NangiaMakker P, Tait L, et al. Alterations in galectin3 expression and distribution correlate with breast cancer progression: functional analysis of galectin3 in breast epithelial e.
  • 9Liu F T, Rabinovich G A. Galectins as modulators of tumour progression[J]. Nat Rev Cancer, 2005,5 (1):29-41.
  • 10Yoshii T, Fukumori T, Honjo Y, et al. Galectin3 phosphorylation is required for its anti apoptotic function and cell cycle arrest[J]. J Biol Chem, 2002,277(9):6852-7.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部